Parallax Volatility Advisers, L.P. Bluebird Bio, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $264,143 - $687,940	-64,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $6,272 - $11,417	700 Added 1.09%	64,900 $648,000
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $209,064 - $390,600	-18,600 Reduced 22.46%	64,200 $1.23 Million
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $1.49 Million - $1.83 Million	82,800 New	82,800 $2.65 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.